Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less ... more

• South Africa Brand Report: Consumers of Acne Preparations

  EURO€ 1,115.00USD$ 1,450.00GBP£ 938.00AUD$ 1,418.00JPY¥ 143,163.00SEK 9 520,00CHF 1'367.00CAD$ 1,478.00 Analytix Business Intelligence, Nov 2010 , Pages: 78
  This comprehensive report examines the South African acne and skin blemish preparations segment : historical market sales (past 5 years), sales forecasts until 2014, local consumer/market trends, competitor...

• South Africa Brand Report: Consumers of Slimming Pills, Powders and Liquids

  EURO€ 1,115.00USD$ 1,450.00GBP£ 938.00AUD$ 1,418.00JPY¥ 143,163.00SEK 9 520,00CHF 1'367.00CAD$ 1,478.00 Analytix Business Intelligence, Nov 2010 , Pages: 75
  This comprehensive report examines the South African slimming pills/powder/liquid segment: historical market sales (past 5 years), sales forecasts until 2014, local consumer/market trends, competitor...

• South Africa Brand Report: Consumers of Headache Pills and Powders

  EURO€ 1,115.00USD$ 1,450.00GBP£ 938.00AUD$ 1,418.00JPY¥ 143,163.00SEK 9 520,00CHF 1'367.00CAD$ 1,478.00 Analytix Business Intelligence, Nov 2010 , Pages: 81
  This comprehensive report examines the South African headache OTC segment : historical market sales (past 5 years), sales forecasts until 2014, local consumer/market trends, competitor analysis of key...

• India's TOP 200 Pharma Company Profiles

  EURO€ 850.00USD$ 1,106.00GBP£ 715.00AUD$ 1,082.00JPY¥ 109,181.00SEK 7 261,00CHF 1'042.00CAD$ 1,127.00 Cygnus Research, Nov 2010 , Pages: 640
  The report on India's Pharma company profiles contains the top 200 Indian pharmaceutical companies based on their revenues in 2009-10 The information on the companies is obtained from their respective...

• Connected for Health. Using Electronic Health Records to Transform Care Delivery

  EURO€ 37.00USD$ 48.00GBP£ 31.00AUD$ 47.00JPY¥ 4,731.00SEK 315,00CHF 45.00CAD$ 49.00 John Wiley and Sons Ltd, Nov 2010 , Pages: 272
  Kaiser Permanente has implemented the largest nongovernmental electronic health record in the world, serving more than 8.6 million Kaiser Permanente members. Called KP HealthConnect, its impact on patient...

• Manual of Pediatric Hematology and Oncology. Edition No. 5

  EURO€ 115.00USD$ 150.00GBP£ 97.00AUD$ 146.00JPY¥ 14,772.00SEK 982,00CHF 141.00CAD$ 152.00 Elsevier Science and Technology, Nov 2010 , Pages: 1058
  This will be the fifth edition of successful clinical manual aimed at all practitioners treating children with cancer and blood diseases, such as leukemia, anemia, and bone marrow failure. As with previous...

• Estonia Pharmaceuticals and Healthcare Report Q1 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Nov 2010 , Pages: 73
  The Estonia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

• ProCure Treatment Centers, Inc. - Product Pipeline Analysis

  EURO€ 576.00USD$ 750.00GBP£ 485.00AUD$ 734.00JPY¥ 74,050.00SEK 4 924,00CHF 707.00CAD$ 764.00 GlobalData, Nov 2010 , Pages: 18
  This report is a source for data, analysis and actionable intelligence on the ProCure Treatment Centers, Inc portfolio of pipeline products The report provides detailed analysis on each pipeline product...

• Stakeholder Insight: Breast Cancer (Hormone Receptor-Negative)

  EURO€ 11,684.00USD$ 15,200.00GBP£ 9,830.00AUD$ 14,867.00JPY¥ 1,500,741.00SEK 99 801,00CHF 14'327.00CAD$ 15,488.00 Datamonitor, Nov 2010 , Pages: 276
  Triple-negative breast cancer offers a significant opportunity to new market entrants while Herceptin dominates the HER-2-positive market While some triple-negative breast cancer (TNBC) patients now...

• Algeria Pharmaceuticals and Healthcare Report Q1 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Nov 2010 , Pages: 66
  The Algeria Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

• Hungary Pharmaceuticals and Healthcare Report Q1 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Nov 2010 , Pages: 89
  The Hungary Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

• Croatia Pharmaceuticals and Healthcare Report Q1 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Nov 2010 , Pages: 87
  The Croatia Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with...

• Industry Insight - CRAMS (Contract Research And Manufacturing Services) in India

  EURO€ 850.00USD$ 1,106.00GBP£ 715.00AUD$ 1,082.00JPY¥ 109,181.00SEK 7 261,00CHF 1'042.00CAD$ 1,127.00 Cygnus Research, Nov 2010 , Pages: 101
  CRAMS (Contract Research And Manufacturing Services) is one of the fastest growing segments in the pharmaceutical and biotechnology industry It pertains to outsourcing research services/ manufacturing...

• Central America Pharmaceuticals and Healthcare Report Q1 2011

  EURO€ 874.00USD$ 1,137.00GBP£ 735.00AUD$ 1,112.00JPY¥ 112,215.00SEK 7 462,00CHF 1'071.00CAD$ 1,158.00 Business Monitor International, Nov 2010 , Pages: 49
  The Central America Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies...

• Pharma Marketing in Latin America

  EURO€ 345.00USD$ 449.00GBP£ 290.00AUD$ 439.00JPY¥ 44,315.00SEK 2 947,00CHF 423.00CAD$ 457.00 FirstWord Publishing, Nov 2010 , Pages: 43
  Unified by geography, culture and language, Latin America nevertheless remains a marketing puzzle for the pharmaceutical industry Although the Internet is increasing in popularity, it is available only...

• Risk Management Handbook for Health Care Organizations. 3 Volume Set. 6th Edition

  EURO€ 297.00USD$ 387.00GBP£ 250.00AUD$ 378.00JPY¥ 38,169.00SEK 2 538,00CHF 364.00CAD$ 394.00 John Wiley and Sons Ltd, Nov 2010 , Pages: 2000
  Continuing its superiority in the health care risk management field, this sixth edition of The Risk Management Handbook for Health Care Organizations is written by the key practitioners and consultant...

• TC Pharmaceuticals in Singapore

  EURO€ 192.00USD$ 250.00GBP£ 162.00AUD$ 245.00JPY¥ 24,683.00SEK 1 641,00CHF 236.00CAD$ 255.00 Datamonitor, Nov 2010 , Pages: 44
  The OTC Pharmaceuticals in Singapore industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry It includes data on market size and segmentation,...

• OTC Pharmaceuticals in Saudi Arabia

  EURO€ 192.00USD$ 250.00GBP£ 162.00AUD$ 245.00JPY¥ 24,683.00SEK 1 641,00CHF 236.00CAD$ 255.00 Datamonitor, Nov 2010 , Pages: 41
  The OTC Pharmaceuticals in Saudi Arabia industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation,...

• OTC Pharmaceuticals in United Arab Emirates

  EURO€ 192.00USD$ 250.00GBP£ 162.00AUD$ 245.00JPY¥ 24,683.00SEK 1 641,00CHF 236.00CAD$ 255.00 Datamonitor, Nov 2010 , Pages: 43
  The OTC Pharmaceuticals in United Arab Emirates industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and...

• OTC Pharmaceuticals in Israel

  EURO€ 192.00USD$ 250.00GBP£ 162.00AUD$ 245.00JPY¥ 24,683.00SEK 1 641,00CHF 236.00CAD$ 255.00 Datamonitor, Nov 2010 , Pages: 42
  The OTC Pharmaceuticals in Israel industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation,...

• OTC Pharmaceuticals in Egypt

  EURO€ 192.00USD$ 250.00GBP£ 162.00AUD$ 245.00JPY¥ 24,683.00SEK 1 641,00CHF 236.00CAD$ 255.00 Datamonitor, Nov 2010 , Pages: 39
  The OTC Pharmaceuticals in Egypt industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation,...

• Antibody Technology Companies 2010

  EURO€ 995.00USD$ 1,294.00GBP£ 837.00AUD$ 1,266.00JPY¥ 127,806.00SEK 8 499,00CHF 1'220.00CAD$ 1,319.00 La Merie Publishing, Nov 2010 , Pages: 283
  Antibody Technology Companies 2010 – A systematic guide through the landscape of antibody technologies and their providers The report “Antibody Technology Companies 2010 – A systematic guide through...

• Alzheimer’s - Treatment, Symptoms and Management

  EURO€ 113.00USD$ 147.00GBP£ 95.00AUD$ 144.00JPY¥ 14,514.00SEK 965,00CHF 139.00CAD$ 150.00 GlobalData, Nov 2010 , Pages: 97
  Alzheimer's disease (AD), also called Alzheimer disease, Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer's, is the most common form of dementia This incurable, degenerative, and terminal...

• Global Biosimilars (Follow-on biologics) Market: An Analysis

  EURO€ 615.00USD$ 800.00GBP£ 517.00AUD$ 782.00JPY¥ 78,986.00SEK 5 253,00CHF 754.00CAD$ 815.00 Koncept Analytics, Nov 2010 , Pages: 36
  Biosimilars or FOBs (Follow-on biologics) refer to generic versions of patented branded biological drugs, developed subsequent to the patent expiry of brand name products The biosimilars market is segmented...

• Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 GlobalData, Nov 2010 , Pages: 357
  Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010 Summary GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Global Drug...

• Colorectal Cancer - Germany Drug Forecasts and Treatment Analysis to 2020

  EURO€ 2,306.00USD$ 3,000.00GBP£ 1,940.00AUD$ 2,934.00JPY¥ 296,199.00SEK 19 698,00CHF 2'828.00CAD$ 3,057.00 GlobalData, Nov 2010 , Pages: 152
  Colorectal Cancer - Germany Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Germany Drug Forecasts...

• Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020

  EURO€ 2,306.00USD$ 3,000.00GBP£ 1,940.00AUD$ 2,934.00JPY¥ 296,199.00SEK 19 698,00CHF 2'828.00CAD$ 3,057.00 GlobalData, Nov 2010 , Pages: 195
  Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Colorectal...

• Colorectal Cancer - Italy Drug Forecasts and Treatment Analysis to 2020

  EURO€ 2,306.00USD$ 3,000.00GBP£ 1,940.00AUD$ 2,934.00JPY¥ 296,199.00SEK 19 698,00CHF 2'828.00CAD$ 3,057.00 GlobalData, Nov 2010 , Pages: 158
  Colorectal Cancer - Italy Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Italy Drug Forecasts and...

• Colorectal Cancer - US Drug Forecasts and Treatment Analysis to 2020

  EURO€ 2,306.00USD$ 3,000.00GBP£ 1,940.00AUD$ 2,934.00JPY¥ 296,199.00SEK 19 698,00CHF 2'828.00CAD$ 3,057.00 GlobalData, Nov 2010 , Pages: 155
  Colorectal Cancer - US Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - US Drug Forecasts and Treatment...

• Colorectal Cancer - Japan Drug Forecasts and Treatment Analysis to 2020

  EURO€ 2,306.00USD$ 3,000.00GBP£ 1,940.00AUD$ 2,934.00JPY¥ 296,199.00SEK 19 698,00CHF 2'828.00CAD$ 3,057.00 GlobalData, Nov 2010 , Pages: 152
  Colorectal Cancer - Japan Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Japan Drug Forecasts and...

• Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020

  EURO€ 2,306.00USD$ 3,000.00GBP£ 1,940.00AUD$ 2,934.00JPY¥ 296,199.00SEK 19 698,00CHF 2'828.00CAD$ 3,057.00 GlobalData, Nov 2010 , Pages: 158
  Colorectal Cancer - France Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - France Drug Forecasts...

• Colorectal Cancer - Spain Drug Forecasts and Treatment Analysis to 2020

  EURO€ 2,306.00USD$ 3,000.00GBP£ 1,940.00AUD$ 2,934.00JPY¥ 296,199.00SEK 19 698,00CHF 2'828.00CAD$ 3,057.00 GlobalData, Nov 2010 , Pages: 152
  Colorectal Cancer - Spain Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - Spain Drug Forecasts and...

• Colorectal Cancer - UK Drug Forecasts and Treatment Analysis to 2020

  EURO€ 2,306.00USD$ 3,000.00GBP£ 1,940.00AUD$ 2,934.00JPY¥ 296,199.00SEK 19 698,00CHF 2'828.00CAD$ 3,057.00 GlobalData, Nov 2010 , Pages: 152
  Colorectal Cancer - UK Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Colorectal Cancer - UK Drug Forecasts and Treatment...

• OTC Pharmaceuticals in South Africa

  EURO€ 154.00USD$ 200.00GBP£ 129.00AUD$ 196.00JPY¥ 19,747.00SEK 1 313,00CHF 189.00CAD$ 204.00 Datamonitor, Nov 2010 , Pages: 36
  The OTC Pharmaceuticals in South Africa industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry It includes data on market size and segmentation,...

• U.S. Inflammatory Diseases Drug Delivery: Physician Perspective

  EURO€ 7,687.00USD$ 10,000.00GBP£ 6,467.00AUD$ 9,781.00JPY¥ 987,330.00SEK 65 658,00CHF 9'425.00CAD$ 10,190.00 Frost & Sullivan, Nov 2010 , Pages: 45
  This study encompasses feedback provided by U S physicians who treat inflammatory diseases on aspects of drug delivery and drug treatment, enabling interested stakeholders to gain insight into current...

• Improving Compliance (Migliorare la compliance)

  EURO€ 9.00USD$ 12.00GBP£ 8.00AUD$ 12.00JPY¥ 1,177.00SEK 78,00CHF 11.00CAD$ 12.00 SEED, Nov 2010 , Pages: 133
  "I’m against drugs " "My father smoked a pack of cigarettes daily for all his life and he died at the age of 82 " "Diagnostic investigations are useless: things happen because of fate " Which physician...

• HIV/AIDS Infection and Comorbidity (Infezione da HIV/AIDS e comorbidità)

  EURO€ 12.00USD$ 16.00GBP£ 10.00AUD$ 15.00JPY¥ 1,541.00SEK 103,00CHF 15.00CAD$ 16.00 SEED, Nov 2010 , Pages: 96
  Thanks to the available therapeutic options, AIDS-related mortality is reduced Nevertheless, in recent years an increase in non-AIDS-related deaths among the HIV-positive community has been recorded...

• Communication in Medicine: Collaboration among Healthcare Professionals (Comunicazione in medicina)

  EURO€ 15.00USD$ 20.00GBP£ 13.00AUD$ 19.00JPY¥ 1,927.00SEK 128,00CHF 18.00CAD$ 20.00 SEED, Nov 2010 , Pages: 108
  Comprehensive care for people, especially those with chronic conditions or comorbidities, requires the co-operation of many specialists Therefore effective and timely communication among all the healthcare...

• Pharmacoeconomics: Basic Principles (Farmacoeconomia: Principi di base)

  EURO€ 9.00USD$ 12.00GBP£ 8.00AUD$ 12.00JPY¥ 1,177.00SEK 78,00CHF 11.00CAD$ 12.00 SEED, Nov 2010 , Pages: 120
  Economic issues related to the health sector have been gaining much attention in recent years, and the challenge of providing quality and comprehensive healthcare to a growing population has become...

• The Patient with Diabetes and Chronic Hepatopathy (Il paziente con diabete ed epatopatia cronica)

  EURO€ 14.00USD$ 18.00GBP£ 12.00AUD$ 17.00JPY¥ 1,766.00SEK 117,00CHF 17.00CAD$ 18.00 SEED, Nov 2010 , Pages: 126
  Diabetes mellitus and chronic hepatopathies comorbidity is common in a large amount of patients, but it is seldom analyzed in available published papers This book provides a concise but complete overview...

• Gender Pharmacology (Farmacologia di genere)

  EURO€ 18.00USD$ 23.00GBP£ 15.00AUD$ 22.00JPY¥ 2,248.00SEK 149,00CHF 21.00CAD$ 23.00 SEED, Nov 2010 , Pages: 163
  Despite the fact that women are the main drugs consumers, randomised clinical trial are usually performed on young males Gender pharmacology has been developed to try to go beyond this gap of knowledge,...

• Risk of Disability in Elderly Diabetic Patients (Il diabete nell’anziano e il rischio di disabilità)

  EURO€ 14.00USD$ 18.00GBP£ 12.00AUD$ 17.00JPY¥ 1,766.00SEK 117,00CHF 17.00CAD$ 18.00 SEED, Nov 2010 , Pages: 103
  In the elderly population, diabetes is often associated with a wide range of complications and comorbidities that can affect the patients’ ability to care for themselves, thus complicating the medical...

• Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 GBI Research, Nov 2010 , Pages: 85
  “Oral Drug Delivery Market - Controlled and Sustained Release to be Major Revenue Generators”, provides the key data and analyzes the major challenges and drivers for the Oral Drug Delivery Market The...

• OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide

  EURO€ 765.00USD$ 995.00GBP£ 643.00AUD$ 973.00JPY¥ 98,239.00SEK 6 533,00CHF 938.00CAD$ 1,014.00 Datamonitor, Nov 2010 , Pages: 192
  The OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the Top 5 Emerging markets...

• Drug Delivery Partnering Terms and Agreements in Pharma and Biotech 2nd Edition

  EURO€ 2,072.00USD$ 2,695.00GBP£ 1,743.00AUD$ 2,636.00JPY¥ 266,085.00SEK 17 695,00CHF 2'540.00CAD$ 2,746.00 CurrentPartnering, Nov 2010 , Pages: 428
  The Drug Delivery Partnering Terms and Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by...

• Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition

  EURO€ 2,072.00USD$ 2,695.00GBP£ 1,743.00AUD$ 2,636.00JPY¥ 266,085.00SEK 17 695,00CHF 2'540.00CAD$ 2,746.00 CurrentPartnering, Nov 2010 , Pages: 324
  The Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter asset purchase deals - Product purchase...

• The Top 30 Developers of Molecular Diagnostic Tests for Breast Cancer

  EURO€ 195.00USD$ 254.00GBP£ 164.00AUD$ 248.00JPY¥ 25,047.00SEK 1 666,00CHF 239.00CAD$ 259.00 Research Facts Ltd, Nov 2010 , Pages: 72
  According to the WHO’s International Agency for Research on Cancer’s most recent estimates, breast cancer is by far the most frequent cancer among women with an estimated 1 38 million new cancer cases...

• OTC Pharmaceuticals in the United Kingdom

  EURO€ 192.00USD$ 250.00GBP£ 162.00AUD$ 245.00JPY¥ 24,683.00SEK 1 641,00CHF 236.00CAD$ 255.00 Datamonitor, Nov 2010 , Pages: 45
  The OTC Pharmaceuticals in the United Kingdom industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and...

• Global OTC Pharmaceuticals

  EURO€ 192.00USD$ 250.00GBP£ 162.00AUD$ 245.00JPY¥ 24,683.00SEK 1 641,00CHF 236.00CAD$ 255.00 Datamonitor, Nov 2010 , Pages: 44
  The Global OTC Pharmaceuticals industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation,...

• OTC Pharmaceuticals in the Netherlands

  EURO€ 192.00USD$ 250.00GBP£ 162.00AUD$ 245.00JPY¥ 24,683.00SEK 1 641,00CHF 236.00CAD$ 255.00 Datamonitor, Nov 2010 , Pages: 43
  The OTC Pharmaceuticals in the Netherlands industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation,...